BrickBio, Inc.
PrivateLast Round
VC Round
Mar 18, 2024
Est. Valuation
$20M
Total Funding Raised
$5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BrickBio, Inc. operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a VC Round in March 2024.
BrickBio, Inc. is a biotechnology company that develops a bioconjugation platform for the site-specific modification of proteins to create novel biologics and therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BrickBio, Inc. Comparables
Compare BrickBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRO Biosciences | 85% | |
| VALANX Biotech | 82% | |
| Lonza Group | 75% |
For institutional investors. Book with your work email.
BrickBio, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BrickBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Samsung Venture Investment | VC Round |
| TigerGene | Series A |
| Samsung Life Science Fund | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 903% MoM, from 145 to 1.5K.
- Jul 26, 2026
Monthly visitors grew 84% MoM, from 79 to 145.
For institutional investors. Book with your work email.
BrickBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BrickBio, Inc.'s valuation, stock price, and market status.
Is BrickBio, Inc. a public or private company?
BrickBio, Inc. is a private company.
What is the current stock price of BrickBio, Inc.?
BrickBio, Inc. is a private company, so its shares have no public market price. Caplight tracks BrickBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BrickBio, Inc. worth (valuation)?
BrickBio, Inc.'s valuation is estimated at $20.0M based on funding round data.
Can I buy BrickBio, Inc. stock?
BrickBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BrickBio, Inc.'s last funding round?
BrickBio, Inc.'s most recent funding round was VC Round on March 18, 2024.
Who are the main investors in BrickBio, Inc.?
Key investors in BrickBio, Inc. include Samsung Venture Investment, TigerGene, Samsung Life Science Fund.
Will BrickBio, Inc. IPO soon?
No public IPO plans have been announced for BrickBio, Inc..
How can I track BrickBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in BrickBio, Inc.'s shares on secondary markets.